Literature DB >> 22449866

Identification of OXA-23-producing Acinetobacter baumannii in Greece, 2010 to 2011.

A Liakopoulos1, V Miriagou, E A Katsifas, A D Karagouni, G L Daikos, L S Tzouvelekis, E Petinaki.   

Abstract

We report on the sequence type and beta-lactamase content of 174 carbapenem-resistant Acinetobacter baumannii isolates recovered from clinical specimens during 2010 and 2011 in a tertiary care hospital in central Greece. Carbapenem resistance was associated mainly with carriage of the bla(OXA-23) gene (in 72.4% of the isolates). To our knowledge, this is the first description of A. baumannii strains producing OXA-23 in Greece. During 2011, in our hospital they rapidly ‘replaced’ the previously predominant OXA-58- positive A. baumannii strains.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22449866

Source DB:  PubMed          Journal:  Euro Surveill        ISSN： 1025-496X


  20 in total

Review 1.  Double- and multi-carbapenemase-producers: the excessively armored bacilli of the current decade.

Authors:  G Meletis; D Chatzidimitriou; N Malisiovas
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-04-18       Impact factor: 3.267

2.  Trends of isolation of intrinsically resistant to colistin Enterobacteriaceae and association with colistin use in a tertiary hospital.

Authors:  G Samonis; I P Korbila; S Maraki; I Michailidou; K Z Vardakas; D Kofteridis; D Dimopoulou; V K Gkogkozotou; M E Falagas
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-04-15       Impact factor: 3.267

3.  Investigation of Metallo Beta Lactamases and Oxacilinases in Carbapenem Resistant Acinetobacter baumannii Strains Isolated from Inpatients.

Authors:  M Duygu Aksoy; Şaban Çavuşlu; H Murat Tuğrul
Journal:  Balkan Med J       Date:  2015-01-01       Impact factor: 2.021

4.  First report of an OXA-23 carbapenemase-producing Acinetobacter baumannii clinical isolate related to Tn2006 in Spain.

Authors:  P Espinal; M D Macià; I Roca; E Gato; E Ruíz; F Fernández-Cuenca; A Oliver; J Rodríguez-Baño; G Bou; M Tomás; J Vila
Journal:  Antimicrob Agents Chemother       Date:  2012-10-15       Impact factor: 5.191

5.  Globally expanding carbapenemase finally appears in Spain: nosocomial outbreak of acinetobacter baumannii producing plasmid-encoded OXA-23 in Barcelona, Spain.

Authors:  Noraida Mosqueda; Paula Espinal; Clara Cosgaya; Sergio Viota; Virginia Plasensia; Francisco Alvarez-Lerma; Milagro Montero; Julià Gómez; Juan Pablo Horcajada; Jordi Vila; Ignasi Roca
Journal:  Antimicrob Agents Chemother       Date:  2013-07-22       Impact factor: 5.191

6.  Molecular Detection of Class-D OXA Carbapenemase Genes in Biofilm and Non-Biofilm Forming Clinical Isolates of Acinetobacter baumannii.

Authors:  Omid Azizi; Mohammad Reza Shakibaie; Farzan Modarresi; Fereshteh Shahcheraghi
Journal:  Jundishapur J Microbiol       Date:  2015-01-12       Impact factor: 0.747

7.  Molecular epidemiology of carbapenem non-susceptible Acinetobacter baumannii in France.

Authors:  Katy Jeannot; Laure Diancourt; Sophie Vaux; Michelle Thouverez; Amandina Ribeiro; Bruno Coignard; Patrice Courvalin; Sylvain Brisse
Journal:  PLoS One       Date:  2014-12-17       Impact factor: 3.240

Review 8.  Epidemiology of carbapenemase-producing Enterobacteriaceae and Acinetobacter baumannii in Mediterranean countries.

Authors:  Nassima Djahmi; Catherine Dunyach-Remy; Alix Pantel; Mazouz Dekhil; Albert Sotto; Jean-Philippe Lavigne
Journal:  Biomed Res Int       Date:  2014-05-13       Impact factor: 3.411

9.  High prevalence of oxacillinases in clinical multidrug-resistant Acinetobacter baumannii isolates from the Tshwane region, South Africa - an update.

Authors:  Michelle Lowings; Marthie Magdaleen Ehlers; Andries William Dreyer; Marleen Magdalena Kock
Journal:  BMC Infect Dis       Date:  2015-11-14       Impact factor: 3.090

10.  Co-occurrence of carbapenem and aminoglycoside resistance genes among multidrug-resistant clinical isolates of Acinetobacter baumannii from Cracow, Poland.

Authors:  Paweł Nowak; Paulina Maria Paluchowska; Alicja Budak
Journal:  Med Sci Monit Basic Res       Date:  2014-01-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.